Hemoglobin A1c testing in diabetes: a rapid review
Health Quality Ontario
Record ID 32014001067
English
Authors' objectives:
This rapid review aimed to determine the frequency of hemoglobin A1c (HbA1c) testing to assess glycemic
control in patients with type 2 diabetes.
Authors' recommendations:
The volume of hemoglobin A1c (HbA1c) tests increased annually in Ontario from fiscal years 2007-2008 to 2011-2012.
Experts conclude that HbA1c should be tested every 3 months when treatments are being adjusted and when glycemic goals are not met in adult patients with diabetes (without hematologic contraindication). Once blood glucose control is stable, HbA1c should be tested every 6 months.
Hemoglobin A1c should not be measured more than 4 times yearly.
Recommendations for the frequency of HbA1c testing are applicable to both type 1 and type 2 diabetes.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
https://www.hqontario.ca/Evidence-to-Improve-Care/Health-Technology-Assessment/Reviews-And-Recommendations/Hemoglobin-A1c-Testing-in-Diabetes
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Diabetes Mellitus, Type 2
- Diabetes Mellitus
- Glycated Hemoglobin
- Diagnostic Tests, Routine
- Point-of-Care Testing
- Self-Management
Contact
Organisation Name:
Health Quality Ontario
Contact Address:
Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5
Contact Name:
EDSinfo@hqontario.ca
Contact Email:
OH-HQO_hta-reg@ontariohealth.ca
Copyright:
Health Quality Ontario
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.